PT2490671E - Lipossomas hidrolizáveis por spla2 com estabilidade de armazenamento melhorada - Google Patents
Lipossomas hidrolizáveis por spla2 com estabilidade de armazenamento melhorada Download PDFInfo
- Publication number
- PT2490671E PT2490671E PT107729568T PT10772956T PT2490671E PT 2490671 E PT2490671 E PT 2490671E PT 107729568 T PT107729568 T PT 107729568T PT 10772956 T PT10772956 T PT 10772956T PT 2490671 E PT2490671 E PT 2490671E
- Authority
- PT
- Portugal
- Prior art keywords
- concentration
- liposomes
- solution
- liposome
- spla2
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200901150A DK177529B1 (en) | 2009-10-23 | 2009-10-23 | Liposomes with improved storage stability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2490671E true PT2490671E (pt) | 2014-05-30 |
Family
ID=43533079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT107729568T PT2490671E (pt) | 2009-10-23 | 2010-10-25 | Lipossomas hidrolizáveis por spla2 com estabilidade de armazenamento melhorada |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9820941B2 (enExample) |
| EP (1) | EP2490671B1 (enExample) |
| JP (1) | JP5778160B2 (enExample) |
| CN (1) | CN102639114B (enExample) |
| AU (1) | AU2010310240B2 (enExample) |
| CA (1) | CA2772973C (enExample) |
| CY (1) | CY1115139T1 (enExample) |
| DK (2) | DK177529B1 (enExample) |
| ES (1) | ES2465565T3 (enExample) |
| HR (1) | HRP20140413T1 (enExample) |
| PL (1) | PL2490671T3 (enExample) |
| PT (1) | PT2490671E (enExample) |
| RS (1) | RS53321B (enExample) |
| SI (1) | SI2490671T1 (enExample) |
| SM (1) | SMT201400065B (enExample) |
| WO (1) | WO2011047689A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2123258A1 (en) | 2008-05-23 | 2009-11-25 | Liplasome Pharma A/S | Liposomes for drug delivery |
| DK177532B1 (en) | 2009-09-17 | 2013-09-08 | Bio Bedst Aps | Medical use of sPLA2 hydrolysable liposomes |
| EP2394640A1 (en) | 2010-05-21 | 2011-12-14 | MediGene AG | Improved liposomal formulations of lipophilic compounds |
| JP6263609B2 (ja) * | 2014-04-30 | 2018-01-17 | 富士フイルム株式会社 | リポソーム組成物及びその製造方法 |
| EP3138558B1 (en) | 2014-04-30 | 2023-06-07 | FUJIFILM Corporation | Liposome composition and production method therefor |
| DK3138555T3 (da) * | 2014-04-30 | 2020-12-14 | Fujifilm Corp | Liposomsammensætning og fremgangsmåde til fremstilling heraf |
| CN107750156B (zh) | 2015-05-04 | 2020-08-21 | 沃桑缇斯股份公司 | 用于制备跨膜pH梯度囊泡的方法 |
| US9725769B1 (en) | 2016-10-07 | 2017-08-08 | Oncology Venture ApS | Methods for predicting drug responsiveness in cancer patients |
| AU2017258901A1 (en) | 2016-12-30 | 2018-07-19 | Allarity Therapeutics Europe ApS | Methods for predicting drug responsiveness in cancer patients |
| AU2019200325A1 (en) * | 2018-01-31 | 2019-08-15 | Liplasome Pharma Aps | Methods for treating cancer and predicting drug responsiveness in cancer patients |
| CN110496103B (zh) * | 2018-05-18 | 2022-05-10 | 上海维洱生物医药科技有限公司 | 一种多西他赛棕榈酸酯脂质体及其制备方法 |
| JP7364561B2 (ja) | 2018-06-20 | 2023-10-18 | 富士フイルム株式会社 | ゲムシタビンを内包するリポソーム組成物および免疫チェックポイント阻害剤を含む組合せ医薬 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880635B1 (en) * | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
| ATE77051T1 (de) | 1988-03-04 | 1992-06-15 | Takeda Chemical Industries Ltd | Liposom-zusammensetzung. |
| JP2931981B2 (ja) * | 1988-03-04 | 1999-08-09 | 武田薬品工業株式会社 | リポソーム製剤およびその製造法 |
| FI895340A7 (fi) * | 1988-11-14 | 1990-05-15 | Bristol Myers Squibb Co | Hypertoninen cisplatin-liuos |
| JPH05194192A (ja) * | 1991-08-21 | 1993-08-03 | Shionogi & Co Ltd | 分散性の改善された温度感受性ｍｌｖ型リポソ−ム |
| JPH069374A (ja) * | 1992-04-07 | 1994-01-18 | Banyu Pharmaceut Co Ltd | リポソ−ム製剤およびその製造法 |
| AU3559695A (en) | 1994-09-30 | 1996-04-26 | Inex Pharmaceuticals Corp. | Glycosylated protein-liposome conjugates and methods for their preparation |
| US5858397A (en) | 1995-10-11 | 1999-01-12 | University Of British Columbia | Liposomal formulations of mitoxantrone |
| WO1998007409A1 (en) * | 1996-08-23 | 1998-02-26 | Sequus Pharmaceuticals, Inc. | Liposomes containing a cisplatin compound |
| FR2759293B1 (fr) * | 1997-02-11 | 1999-04-30 | Ethypharm Lab Prod Ethiques | Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie |
| ATE277935T1 (de) | 2000-02-10 | 2004-10-15 | Liplasome Pharma As | Auf lipiden basierende systeme zur arzneistoffabgabe |
| ES2280355T3 (es) | 2000-04-12 | 2007-09-16 | Liplasome Pharma A/S | Sistema de administracion de medicamentos basados en lipidos para su utilizacion en la piel. |
| US20030026831A1 (en) | 2001-04-20 | 2003-02-06 | Aparna Lakkaraju | Anionic liposomes for delivery of bioactive agents |
| CA2383259A1 (en) | 2002-04-23 | 2003-10-23 | Celator Technologies Inc. | Synergistic compositions |
| EP1443900B1 (en) | 2001-11-13 | 2012-05-23 | Celator Pharmaceuticals, Inc. | Lipid carrier compositions with enhanced blood stability |
| US20040022842A1 (en) | 2002-06-03 | 2004-02-05 | Mebiopharm Co., Ltd. | Liposome preparations containing oxaliplatin |
| WO2005000266A2 (en) | 2003-05-22 | 2005-01-06 | Neopharm, Inc. | Liposomal formulations comprising a combination of two or more active agents |
| GB0312309D0 (en) * | 2003-05-29 | 2003-07-02 | Gaslini Children S Hospital G | Targeted liposome |
| JPWO2006025411A1 (ja) | 2004-08-31 | 2008-05-08 | アステラス製薬株式会社 | 細胞内薬物送達改善リポソーム |
| DE602005012155D1 (de) | 2004-11-03 | 2009-02-12 | Liplasome Pharma As | Arzneimittelabgabesysteme auf lipidbasis mit unnatürlichen phospholipase-a2-abbaubaren lipid-derivaten und ihre therapeutische verwendung |
| WO2007005754A2 (en) * | 2005-07-01 | 2007-01-11 | Alza Corporation | Liposomal delivery vehicle for hydrophobic drugs |
| CN101040853B (zh) * | 2006-03-22 | 2010-05-12 | 上海医药工业研究院 | 一种草乌甲素多泡脂质体及其制备方法 |
| JP2009530318A (ja) | 2006-03-23 | 2009-08-27 | リプラサム ファーマ アー／エス | 加水分解時に分子内環化反応を行うホスホリパーゼａ２分解性脂質を含む脂質ベース薬剤送達系 |
| WO2008006658A1 (en) | 2006-07-14 | 2008-01-17 | Fmc Biopolymer As | Hydrogels containing low molecular weight alginates and biostructures made therefrom |
| CN100563646C (zh) * | 2007-07-13 | 2009-12-02 | 陈祥峰 | 一种奥沙利铂脂质体葡萄糖制剂的制备方法 |
| EP2123258A1 (en) * | 2008-05-23 | 2009-11-25 | Liplasome Pharma A/S | Liposomes for drug delivery |
-
2009
- 2009-10-23 DK DKPA200901150A patent/DK177529B1/en not_active IP Right Cessation
-
2010
- 2010-10-25 EP EP10772956.8A patent/EP2490671B1/en active Active
- 2010-10-25 ES ES10772956.8T patent/ES2465565T3/es active Active
- 2010-10-25 PT PT107729568T patent/PT2490671E/pt unknown
- 2010-10-25 CN CN201080047402.7A patent/CN102639114B/zh not_active Expired - Fee Related
- 2010-10-25 SI SI201030638T patent/SI2490671T1/sl unknown
- 2010-10-25 US US13/503,614 patent/US9820941B2/en active Active
- 2010-10-25 WO PCT/DK2010/050283 patent/WO2011047689A2/en not_active Ceased
- 2010-10-25 HR HRP20140413AT patent/HRP20140413T1/hr unknown
- 2010-10-25 RS RS20140274A patent/RS53321B/sr unknown
- 2010-10-25 DK DK10772956.8T patent/DK2490671T3/da active
- 2010-10-25 PL PL10772956T patent/PL2490671T3/pl unknown
- 2010-10-25 AU AU2010310240A patent/AU2010310240B2/en not_active Ceased
- 2010-10-25 JP JP2012534543A patent/JP5778160B2/ja not_active Expired - Fee Related
- 2010-10-25 CA CA2772973A patent/CA2772973C/en active Active
-
2014
- 2014-05-30 CY CY20141100387T patent/CY1115139T1/el unknown
- 2014-06-05 SM SM201400065T patent/SMT201400065B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK177529B1 (en) | 2013-09-08 |
| CA2772973A1 (en) | 2011-04-28 |
| US9820941B2 (en) | 2017-11-21 |
| US20120219618A1 (en) | 2012-08-30 |
| DK2490671T3 (da) | 2014-06-16 |
| PL2490671T3 (pl) | 2014-08-29 |
| WO2011047689A2 (en) | 2011-04-28 |
| WO2011047689A3 (en) | 2011-11-17 |
| SI2490671T1 (sl) | 2014-07-31 |
| DK200901150A (en) | 2011-04-24 |
| CA2772973C (en) | 2017-08-15 |
| JP2013508315A (ja) | 2013-03-07 |
| EP2490671B1 (en) | 2014-03-05 |
| ES2465565T3 (es) | 2014-06-06 |
| AU2010310240B2 (en) | 2015-11-26 |
| CN102639114A (zh) | 2012-08-15 |
| AU2010310240A1 (en) | 2012-03-22 |
| CN102639114B (zh) | 2015-04-01 |
| JP5778160B2 (ja) | 2015-09-16 |
| SMT201400065B (it) | 2014-07-07 |
| RS53321B (sr) | 2014-10-31 |
| HRP20140413T1 (hr) | 2014-07-04 |
| EP2490671A2 (en) | 2012-08-29 |
| CY1115139T1 (el) | 2016-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2490671E (pt) | Lipossomas hidrolizáveis por spla2 com estabilidade de armazenamento melhorada | |
| US11173178B2 (en) | Liposomes for drug delivery and methods for preparation thereof | |
| ES3036518T3 (en) | Stabilizing camptothecin pharmaceutical compositions | |
| US20080213353A1 (en) | Method for preparing liposome formulations with a predefined release profile | |
| TWI362931B (en) | Irinotecan formulation | |
| US10722466B2 (en) | Liposomal formulation for use in the treatment of cancer | |
| JP2015502400A (ja) | リポソームの亜塩素酸塩または塩素酸塩組成物 | |
| TW202320803A (zh) | 製備脂質體調配物之方法 | |
| JP2015010069A (ja) | ポリエンマクロライド系抗生物質の液状プレミックス製剤、その製造方法 | |
| EP4370098A1 (en) | Liposomal formulations of bcl inhibitors |